Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical trials, ENGOT and use of bevacizumab against angiogenesis

Prof Christian Marth - Innsbruck Medical University, Austria
Clinical trials, ENGOT and use of bevacizumab against angiogenesis ( Prof Christian Marth - Innsbruck Medical University, Austria )
1 Nov 2013

Emerging sentinel node in cervical cancer

Prof David Cibula - Charles University Hospital, Prague, Czech Republic
Emerging sentinel node in cervical cancer ( Prof David Cibula - Charles University Hospital, Prague, Czech Republic )
1 Nov 2013

Emotional and physical effects of cancer in life after treatment

Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany
Emotional and physical effects of cancer in life after treatment ( Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany )
1 Nov 2013

Selecting treatment methods for cervical cancer

Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France
Selecting treatment methods for cervical cancer ( Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France )
1 Nov 2013

Results of the ICON7, phase III clinical trial

Prof Eric Pujade-Lauraine - Université de Paris Descartes, France
Results of the ICON7, phase III clinical trial ( Prof Eric Pujade-Lauraine - Université de Paris Descartes, France )
1 Nov 2013

Radium-223: A breakthrough in treatment for advanced prostate cancer?

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
Radium-223: A breakthrough in treatment for advanced prostate cancer? ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
1 Nov 2013

Genomic test to guide breast cancer treatment decisions approved in UK

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
Genomic test to guide breast cancer treatment decisions approved in UK ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
31 Oct 2013

What does NICE approval for Oncotype Dx in breast cancer mean?

Prof Justin Stebbing - Imperial College London, UK
What does NICE approval for Oncotype Dx in breast cancer mean? ( Prof Justin Stebbing - Imperial College London, UK )
31 Oct 2013

Overview of the 2013 ESGO scientific programme

Prof John Green – University of Liverpool, UK
Overview of the 2013 ESGO scientific programme ( Prof John Green – University of Liverpool, UK )
31 Oct 2013

Treatment guidelines for endometrial cancer and increased rates of incidence

Prof John Green - University of Liverpool, UK
Treatment guidelines for endometrial cancer and increased rates of incidence ( Prof John Green - University of Liverpool, UK )
31 Oct 2013

Understanding the causes of endometrial cancer

Prof Martin Widschwendter - University College London Hospital, UK
Understanding the causes of endometrial cancer ( Prof Martin Widschwendter - University College London Hospital, UK )
31 Oct 2013

Disparities in ovarian and cervical cancer screening across Europe

Prof Vesna Kesic - ESGO President Elect
Disparities in ovarian and cervical cancer screening across Europe ( Prof Vesna Kesic - ESGO President Elect )
31 Oct 2013